DALLAS, July 20, 2017 -- Primoris Services Corporation (NASDAQ:PRIM) (“Primoris” or “Company”) today announced a new industrial award valued at over $40 million. The contract was secured by Primoris Industrial Constructors, part of the Power, Industrial, and Engineering segment.
- The project was awarded by a major E&C company for a major chemical manufacturer and supplier for work in Freeport, Texas.
- The project scope of work includes process equipment foundations, underground electrical, asphalt road paving, underground piping, and mass backfill for a new greenfield monoethylene glycol manufacturing facility.
- Work is scheduled to commence in the third quarter of 2017, and completion is expected in the second quarter of 2019.
ABOUT PRIMORIS
Founded in 1960, Primoris, through various subsidiaries, has grown to become one of the largest publicly traded specialty construction and infrastructure companies in the United States. Serving diverse end-markets, Primoris provides a wide range of construction, fabrication, maintenance, replacement, water and wastewater, and engineering services to major public utilities, petrochemical companies, energy companies, municipalities, state departments of transportation, and other customers. Growing both organically and through acquisitions, the Company’s national footprint now extends nearly nationwide and into Canada. For additional information, please visit www.prim.com.
FORWARD-LOOKING STATEMENTS
This press release contains certain forward-looking statements, including with regard to the Company’s future performance. Words such as "estimated," "believes," "expects," "projects," “may,” and "future" or similar expressions are intended to identify forward-looking statements. Forward-looking statements inherently involve known and unknown risks, uncertainties, and other factors, including without limitation, those described in this press release and those detailed in the "Risk Factors" section and other portions of our Annual Report on Form 10-K for the period ended December 31, 2016, and other filings with the Securities and Exchange Commission. Given these uncertainties, you should not place undue reliance on forward-looking statements. Primoris does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Company Contact
Kate Tholking
Director of Investor Relations
(214) 740-5615
[email protected]


FDA Approves Mitapivat for Anemia in Thalassemia Patients
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Italy Fines Apple €98.6 Million Over App Store Dominance
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



